In the present study, a correlation between PDGFRA gain/amplification and CDKN2A homozygous loss was seen, and might imply that astrocytoma with alteration of PDGFR is associated with “RTK I” GBM. This evidence concerns the gene PDGFRB and astrocytoma (excluding glioblastoma).